Search / 369 results found

from
to

SAN FRANCISCO and SEATTLE, July 14, 2021 /PRNewswire/ -- Curebase, a company committed to democratizing access to clinical studies, and InBios International Inc., a leading developer of diagnostic tests for emerging infectious diseases, today announced that InBios successfully utilized Curebase's virtual site solution to power clinical studies for its SCoV-2 Ag Detect™ Rapid Test, which was granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) on May 6, 2021.

  • Updated

SEATTLE, July 14, 2021 /PRNewswire/ -- Kineta Inc, through its subsidiary Kineta Chronic Pain LLC, announced today that the first participant has been successfully dosed in a Phase 1 multiple ascending dose (MAD) clinical trial of KCP506, an investigational, first-in-class α9α10 nicotinic acetylcholine receptor (nAChR) antagonist in development for the treatment of chronic neuropathic pain.

  • Updated

WASHINGTON, July 12, 2021 /PRNewswire/ -- The National Electrical Contractors Association (NECA) is proud to announce the launch of the NECA Innovation Institute, a new program designed to develop the next generation of leaders and innovators in the electrical construction industry. This one-year professional training program will empower participants to become visionary thinkers with the leadership skills needed for practical deployment.

  • Updated

TRI-CITIES — The Tri-City Rush Professional Indoor Football organization will hold its first round of tryouts on Sunday, January 10, at the Southridge Sports Complex in Kennewick, 2901 Southridge Blvd., from 12 to 3 p.m.

  • Updated

SUNNYSIDE — The Sunnyside Police Department will be hosting a drive-through Trunk-or-Treat and non-perishable Food Drive Collection event on October 29, 5-8 p.m., Golob Landing at the entrance of E. Edison Ave. and Van Nutley Dr.